Form 4 for RCUS Arcus Biosciences, Inc.
Accepted 2024-08-15 00:00:00 ET · period of report 2024-08-13 · accession 0001724521-24-000141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | 2024-08-13 | RCUS | Azoy Alexander | CAO | S - Sale | $14.97 | -1,357 | 19.1K | -7% | -$20.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-13 | S | D | 1,357 | $14.97 | 19,070 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 10, 2024. (F2) Consists of 1,357 shares purchased on 5/31/2024 through the Company's Employee Stock Purchase Plan. |